扶正补血颗粒辅治重型再生障碍性贫血临床研究被引量：1

下载PDF

导出

摘要再生障碍性贫血（aplastic anemia,AA）简称再障,通常指原发性骨髓造血功能衰竭综合征,根据患者的病情、血象、骨髓象及预后,可分为重型再生障碍性贫血（severe aplastic anemia,SAA）和非重型再生障碍性贫血（non-severe aplastic anemia,NSAA）[1].目前,常规西医治疗以免疫抑制剂、雄激素等为主,笔者在环孢素胶囊、十一酸睾丸酮用药的基础上,加用扶正补血颗粒治疗SAA 患者30 例,取得较好疗效,现报道如下.

作者潘月芬吴霞雯

机构地区浙江省湖州市中心医院血液科

出处《浙江中西医结合杂志》 2012年第4期285-287,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine

关键词重型再生障碍性贫血扶正补血颗粒环孢素胶囊十一酸睾丸酮

分类号 R556 [医药卫生—血液循环系统疾病]

引文网络
相关文献

参考文献8

1Kamio T,Ito E,Ohara A. Relapse of aplastic anemia in children after immunosuppressive therapy:a report from the Japan Childhood Aplastic Anemia Study Group[J].Haematolgia,2011,(06):814-819.
2张之南.血液病诊断及疗效标准[M]北京:科学出版社,200639-42.
3陈健一,李晓惠,倪海雯,杨月艳.血复生联合环孢素、雄激素治疗再生障碍性贫血35例临床观察[J].四川中医,2007,25(11):66-67. 被引量：8
4刘素平,梁勇,孙晓静,杨淑莲,王继亮.清开灵注射液治疗急性再生障碍性贫血疗效观察[J].中国中医急症,2009,18(9):1446-1447. 被引量：5
5Geissler K. Pathophysiology and treatment of aplastic anemia[J].Wiener Klinische Wochenschrift,2003,(13-14):444-450.
6王耀平,陈静,陈静,汤静燕,顾龙君.同种异基因造血干细胞移植救治极重型急性再生障碍性贫血的经验[J].中国实用儿科杂志,2005,20(11):653-655. 被引量：2
7郭剑锋,章亚成,沈群.章亚成治疗再生障碍性贫血经验[J].山西中医,2009(5):9-10. 被引量：2
8胡秉风,王婷.扶正补血颗粒对再生障碍性贫血患者CD_(34)^+和Fas抗原表达的影响[J].中国社区医师（医学专业）,2011,13(10):216-216. 被引量：1

二级参考文献14

1石清照,徐之良,汪晖,江钟炎.当归注射液对免疫诱导再生障碍性贫血小鼠骨髓细胞组织形态及超微结构的影响[J].实用儿科临床杂志,2005,20(1):20-21. 被引量：5
2杨淑莲,张文艺,王东侠,侯伟,乔子剑,张广舫,李松坡.凉血解毒汤治疗急性再生障碍性贫血的机制探讨[J].中医杂志,2007,48(3):230-231. 被引量：14
3张之南.血液病诊断及疗效标准[M].第3版.北京:科学出版社,2006:39-42.
4Bacigalupo A, Brand R, Oneto R, et al. Treatment of acquired severea plastic anemia:bone marrow transplantation compared with immunosuppressive therapy-the european group for blood and marrow transplantation experience. Semin Hemato1,2000,37: 69-80.
5Kook H, Ristand A, Zeng W, et al. Changes in T-cell receptor Vb repetoire in aplastic anemia: effects of different immunosuppressive regimens. Blood, 2002,99: 3668-3675.
6Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemias. N Engl J Med,1997 ,336:1365-1372.
7Deeg HJ,Amylon MD,Harris RE,et al. Marrow transplant from unrelated donors for patients with aplastic anemia, minimal effective dose of total body irradiation. Biol Blood Marrow Transplants,2001,7:208-219.
8Champlin RE, Perez WS, Passweg J, et al. Addition of anti-thymocyte globulin (ATG) to cyclophasphamide (CY) for HLA-identical sibling allogeneic bone marrow transplantation (BMT) for severe aplastic anemias (SAA):results of a randomized controlled trial. Blood,2003:269a.
9Bacigolupo A, Locatelli F, Socie EP, et al. Fludarabine, cyclophosphamide and ATG for alternative donor transplants in aplastic anemia:a report of the EBMT SAA working party. Bone Marrow Transplant,2002,29(Suppl 2):3120.
10Gupta V, Ball SE, Sage DE,et al. Marrow transplants from unrelated donors for severe aplastic anemia using a compath-IH, fludarabine and cyclophosphamide based conditioning:favourable impact on engraftment and graft-versus-host disease, 2004. Submitted to Blood Reviews.